Načítá se...
A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer
BACKGROUND: The high cost and the long time required to bring drugs into commerce is driving efforts to repurpose FDA approved drugs—to find new uses for which they weren’t intended, and to thereby reduce the overall cost of commercialization, and shorten the lag between drug discovery and availabil...
Uloženo v:
| Vydáno v: | BMC Med Genomics |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4967295/ https://ncbi.nlm.nih.gov/pubmed/27475327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-016-0212-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|